AlgaeCytes Ltd, based at Discovery Park, Sandwich, Kent, has developed a production technology to deliver commercial quantities of Omega 3 oils derived from a proprietary strain of freshwater algae.
The Company established its first 10,000 litre production plant in late 2017 which marked the beginning of the Company’s next phase, the commercialisation of Omega 3 production, enabling the Company to upscale production and target a number of key markets such as nutritional therapeutics, skin care, and other consumer applications.
The Company employs a photobioreactor system and freshwater algal strains to produce high purity Omega 3 oils EPA. High quality protein and carbohydrates are also produced from the remaining algal biomass.
|Product||Technology Growth EIS|
|Sector||Omega 3 Production|
|Aim of funding||Growth|
|HMRC Advanced Assurance received||Yes|
|Envisaged investor exit||4-5 years|
|Targeted return||In excess of 4x capital invested|